Conflicts of Interest

The authors declare no competing interests.

Acknowledgements

We would like to express our sincere gratitude to Guillermo L Chantada, Ricardo dos Reis, and Martins Fideles dos Santos Neto for their valuable suggestions and contributions to this scientific article. Their insights and expertise have greatly enhanced the quality of our work, and we are truly appreciative of their collaborative spirit and dedication to advancing scientific knowledge in this field.

References

1. Pruteanu DP, Olteanu DE, Cosnarovici R, Mihut E, Nagy V. Genetic predisposition in pediatric oncology. Med Pharm Rep. 2020;93(4):323-334.
2. Abdolvahabi A, Taylor BW, Holden RL, et al. Colorimetric and longitudinal analysis of leukocoria in recreational photographs of children with retinoblastoma. PLoS One. 2013;8(10):e76677.
3. Bernard A, Xia SZ, Saleh S, et al. EyeScreen: Development and potential of a novel machine learning application to detect leukocoria. Ophthalmol Sci. 2022;2(3):100158.
4. Erwenne’ CM, Franc EL. Age and lateness of referral as determinants of extra- ocular retinoblastoma. Ophthalmic Paediatrioy and Generics. 1989;10:179-184.
5. Kaliki S, Ji X, Zou Y, et al. Lag Time between Onset of First Symptom and Treatment of Retinoblastoma: An International Collaborative Study of 692 Patients from 10 Countries. doi:10.3390/12
6. Chantada GL. Retinoblastoma: lessons and challenges from developing countries. Ellsworth Lecture 2011. Ophthalmic Genet. 2011;32(4):196-203.
7. Mattosinho CC de S, Grigorovski N, Lucena E, Ferman S, Soares de Moura ATM, Portes AF. Prediagnostic Intervals in Retinoblastoma: Experience at an Oncology Center in Brazil. J Glob Oncol. 2017;3(4):323-330.
8. Al-Haddad C, Bashour Z, Farah L, et al. Establishment of a formal program for retinoblastoma: Feasibility of clinical coordination across borders and impact on outcome. Pediatr Blood Cancer. 2019;66(11):e27959.
9. Joseph B, Shanmugam MP, Srinivasan MK, Kumaramanickavel G. Genetic Testing versus Conventional Clinical Screening in India. O Mol Diagn. 2004;8(4):237-243.
10. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
11. Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Manual for Evidence Synthesis. JBI; 2020. doi:10.46658/JBIMES-20-06
12. Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc. 2015;13(3):147-153.
13. Joseph B, Madhavan J, Mamatha G, Ramprasad VL, Gopal L, Kumaramanickavel G. Retinoblastoma: a diagnostic model for India. Asian Pac J Cancer Prev. 7 2006;7(3):485-488.
14. Guillermo L. Chantada ,Ira J. Dunkel, Paula S. Schaiquevich, Edith L. Grynszpancholc, Jasmine Francis, Alejandro Ceciliano, Pedro A. Zubizarreta, Adriana C. Fandi~no ,David H. Abramson. Twenty-Year Collaboration Between North American and South American Retinoblastoma Programs.American Society of Clinical Oncology. 2016;2(6). doi:10.1200/JGO.2015.002782
15. Howard SC, Zaidi A, Cao X, et al. The My Child Matters programme: effect of public-private partnerships on paediatric cancer care in low-income and middle-income countries. Lancet Oncol. 2018;19(5):e252-e266.
16. Wilimas JA, Wilson MW, Haik BG, et al. Development of retinoblastoma programs in Central America. Pediatr Blood Cancer. 2009;53(1):42-46.
17. Ademola-Popoola DS, Olatunji VA. Retinal imaging with smartphone. Niger J Clin Pract. 2017;20(3):341-345.
18. Al-Nawaiseh I, Ghanem AQ, Yousef YA. Familial Retinoblastoma: Raised Awareness Improves Early Diagnosis and Outcome. J Ophthalmol. 2017;2017:5053961.
19. Kaliki S, Gupta Rathi S, Patel A. Routine fundus screening of families of children with retinoblastoma: A prospective study of 131 consecutive families.Retina. 2019;39(7):1326-1332.
20. Khedekar A, Devarajan B, Ramasamy K, Muthukkaruppan V, Kim U. Smartphone-based application improves the detection of retinoblastoma. Eye . 2019;33(6):896-901.
21. Vargas-Cuentas NI, Medina FF, Villarreal KR. System for the Early Detection of Retinoblastoma.2019 IEEE 39th Central America and Panama Convention (CONCAPAN XXXIX). Published online 2019:1-5.
22. Yousef YA, Alkhoms A, AlJabari R, et al. Programmed screening for retinoblastoma enhances early diagnosis and improves management outcome for high-risk children.Ophthalmic Genet. 2020;41(4):308-314.
23. Thirumalairaj K, Abraham A, Devarajan B, et al. A stepwise strategy for rapid and cost-effective RB1 screening in Indian retinoblastoma patients. J Hum Genet. 2015;60(9):547-552.
24. Antoneli CBG, Steinhorst F, Ribeiro K de CB, et al. O papel do pediatra no diagnóstico precoce do retinoblastoma. Rev Assoc Med Bras. 2004;50(4):400-402.
25. Elfalah M, AlNawaiseh T, Atoum D, et al. Improving Medical Students’ Awareness About Retinoblastoma: A Practical Strategy. Clin Ophthalmol. 2022;16:1807-1814.
26. Hill JA, Lee SY, Njambi L, Corson TW, Dimaras H. Cancer genetics education in a low- to middle-income country: evaluation of an interactive workshop for clinicians in Kenya. PLoS One. 2015;10(6):e0129852.
27. Leander C, Fu LC, Peña A, et al. Impact of an education program on late diagnosis of retinoblastoma in Honduras. Pediatr Blood Cancer. 2007;49(6):817-819.
28. Hill JA, Kimani K, White A, et al. Achieving optimal cancer outcomes in East Africa through multidisciplinary partnership: a case study of the Kenyan National Retinoblastoma Strategy group. Global Health. 2016;12(1):23.
29. Qaddoumi I, Nawaiseh I, Mehyar M, et al. Team management, twinning, and telemedicine in retinoblastoma: a 3-tier approach implemented in the first eye salvage program in Jordan. Pediatr Blood Cancer. 2008;51(2):241-244.
30. Yousef YA, Al-Nawaiseh I, Mehyar M, et al. How Telemedicine and Centralized Care Changed the Natural History of Retinoblastoma in a Developing Country: Analysis of 478 Patients. Ophthalmology. 2021;128(1):130-137.
31. Traore F, Togo B, Sylla F, et al. Le rétinoblastome : état des lieux au Mali et programme d’aide au diagnostic précoce, aux traitements et à la réhabilitation.Bull Cancer. 2013;100(2):161-165.
32. Chantada GL, Fandiño AC, Raslawski EC, et al. Experience with chemoreduction and focal therapy for intraocular retinoblastoma in a developing country. Pediatr Blood Cancer. 2005;44(5):455-460.
33. Chantada G, Doz F, Antoneli CBG, et al. A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer. 2006;47(6):801-805.
34. Soliman SE, Dimaras H, Khetan V, et al. Prenatal versus Postnatal Screening for Familial Retinoblastoma. Ophthalmology. 2016;123(12):2610-2617.
35. Rodriguez-Galindo C, Wilson MW, Chantada G, et al. Retinoblastoma: One World, One Vision.Pediatrics. 2008;122(3):e763-e770.
36. Leal-Leal C, Flores-Rojo M, Medina-Sansón A, et al. A multicentre report from the Mexican Retinoblastoma Group. Br J Ophthalmol. 2004;88(8):1074-1077.
37. CureAll framework: WHO global initiative for childhood cancer. WHO global initiative for childhood cancer. Accessed September 1, 2024. https://www.who.int/publications/i/item/9789240025271
38. Dimaras H, Corson TW, Cobrinik D, et al. Retinoblastoma. Nat Rev Dis Primers. 2015;1:15021.
39. Ademola-Popoola DS, Opocher E, Ashwin Reddy M. Contemporary management of retinoblastoma in the context of a low-resource country. Niger Postgrad Med J. 2019;26(2):69.
40. Nyamori JM, Kimani K, Njuguna MW, Dimaras H. Retinoblastoma referral pattern in Kenya.Middle East Afr J Ophthalmol. 2014;21(4):321-327.
41. Mattosinho CCDS, Moura ATMS, Oigman G, Ferman SE, Grigorovski N. Time to diagnosis of retinoblastoma in Latin America: A systematic review. Pediatr Hematol Oncol. 2019;36(2):55-72.
42. Jabir AR, Zaheer HA, Zaheer MA, Zaheer EA, Birdsong R. Detection and Diagnosis of Retinoblastoma: Can Mobile Devices Be the Next Step Toward Early Intervention? Cureus. 2022;14(10):e30074.
43. Croswell JM, Ransohoff DF, Kramer BS. Principles of cancer screening: lessons from history and study design issues. Semin Oncol. 2010;37(3):202-215.
44. World report on vision. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO.
45. Leal-Leal CA, Dilliz-Nava H, Flores-Rojo M, Robles-Castro J. First contact physicians and retinoblastoma in Mexico. Pediatr Blood Cancer. 2011;57(7):1109-1112.